Your browser doesn't support javascript.
loading
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
Tartaglia, Lawrence J; Chang, Hui-Wen; Lee, Benjamin C; Abbink, Peter; Ng'ang'a, David; Boyd, Michael; Lavine, Christy L; Lim, So-Yon; Sanisetty, Srisowmya; Whitney, James B; Seaman, Michael S; Rolland, Morgane; Tovanabutra, Sodsai; Ananworanich, Jintanat; Robb, Merlin L; Kim, Jerome H; Michael, Nelson L; Barouch, Dan H.
Afiliación
  • Tartaglia LJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Chang HW; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Lee BC; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Ng'ang'a D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Boyd M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Lavine CL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Sanisetty S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Whitney JB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Seaman MS; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
  • Rolland M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Tovanabutra S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
  • Ananworanich J; U.S. Government Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Robb ML; U.S. Government Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Kim JH; U.S. Government Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Michael NL; U.S. Government Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Barouch DH; U.S. Government Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
PLoS Pathog ; 12(2): e1005431, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26849216

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Síndrome de Inmunodeficiencia Adquirida del Simio / VIH-1 / Virus de la Inmunodeficiencia de los Simios / Vacunas contra el SIDA Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Síndrome de Inmunodeficiencia Adquirida del Simio / VIH-1 / Virus de la Inmunodeficiencia de los Simios / Vacunas contra el SIDA Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos